To effectively address critical questions related to the adoption and deployment of in silico methods for specific topics, the Avicenna Alliance has established dedicated Task Forces, composed of experts from various fields, ensuring a multidisciplinary approach to solving complex issues.
These groups collaborate to achieve concrete progress for matters as diverse as In silico AI, Patient involvement, Horizon Europe Projects, Pharmaceutical strategy, In silico oncology, Notified Bodies and Standard Organizations, etc.
By leveraging diverse expertise and fostering strong industry-academia relationships – each Task Force is led by 2 co-chairs one from academia and one from industry - the Task Forces aim to pave the way for widespread implementation and acceptance of in silico practices, ultimately benefiting patients and advancing scientific progress.
NEWS
News
Advancing the regulatory acceptance of in silico technologies
Our International Affairs Working Group Leader, Marc Horner, represented the Avicenna Alliance at the Regulatory Affairs Professionals Society (RAPS) #RAPSConvergence2026 in Charlotte, North Carolina.
News
Welcome DARERL to the Avicenna Alliance!
What if medical devices could be tested on hundreds of virtual humans before being tested on a single real one?
News
100,000+ accesses — and counting!
The Avicenna Alliance is delighted to celebrate a major milestone: the In Silico book has reached 100,000 accesses!